Long-term benefit of direct-acting antivirals on gut dysbiosis and microbial translocation in HCV-infected patients with and without HIV coinfection

被引：0
|
作者：
Chuaypen, Natthaya [1 ]
Jinato, Thananya [1 ]
Tangkijvanich, Pisit [1 ]
机构：
[1] Chulalongkorn Univ, Fac Med, Biochem, Bangkok, Thailand
来源：
JOURNAL OF HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-243
引用
收藏
页码：S354 / S355
页数：2
相关论文
共 50 条
  • [21] Timing Strategies of Direct-Acting Antivirals and Biologics Administration in HCV-Infected Subjects with Inflammatory Bowel Diseases
    Imperatore, Nicola
    Castiglione, Fabiana
    Rispo, Antonio
    Sessa, Anna
    Caporaso, Nicola
    Morisco, Filomena
    FRONTIERS IN PHARMACOLOGY, 2017, 8
  • [22] Memory re-differentiation and reduced lymphocyte activation in chronic HCV-infected patients receiving direct-acting antivirals
    Burchill, M. A.
    Golden-Mason, L.
    Wind-Rotolo, M.
    Rosen, H. R.
    JOURNAL OF VIRAL HEPATITIS, 2015, 22 (12) : 983 - 991
  • [23] Lipid Profiles After Therapy with Direct-Acting Antivirals in HCV Mono-infected and HCV/HIV Co-infected Patients
    Simmons, Okeefe L.
    Drechsler, Henning
    Kouma, Marcus
    Brown, Geri
    Bedimo, Roger
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S343 - S343
  • [24] Will direct-acting antivirals make a difference in HIV-HCV coinfected patients?
    Bruno, Raffaele
    Fagiuoli, Stefano
    Sacchi, Paolo
    EXPERT REVIEW OF ANTI-INFECTIVE THERAPY, 2011, 9 (09) : 699 - 701
  • [25] Timing of treatment initiation of direct-acting antivirals for HIV/HCV coinfected and HCV monoinfected patients
    Rice, Donald P.
    Ordoveza, Michelle A.
    Palmer, Ann M.
    Wu, George Y.
    Chirch, Lisa M.
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2018, 30 (12): : 1507 - 1511
  • [26] HCV cure with direct-acting antivirals in HIV/HCV coinfected patients belonging to key populations
    Oprea, Cristiana
    Ianache, Irina
    Costescu, Cristiana
    Piscu, Sebastian
    Vasile, Sorina
    Ene, Luminita
    Radoi, Roxana
    Popa, Ionut
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 326 - 326
  • [27] Response to direct-acting antivirals for hepatitis C treatment in vertically HIV/HCV co-infected patients
    Carrasco, Itziar
    Sainz, Talia
    Antoinette Frick, Marie
    Jimenez de Ory, Santiago
    Fortuny, Claudia
    Burgos, Joaquin
    Montero, Marta
    Gavilan, Cesar
    Dolores Falcon, Maria
    Antonio Couceiro, Jose
    Ignacio Bernardino, Jose
    Bisbal, Otilia
    Guerrero, Carmelo
    Teresa Aldamiz-Echevarria, Maria
    Berenguer, Juan
    Luisa Navarro, Maria
    JOURNAL OF VIRAL HEPATITIS, 2020, 27 (09) : 955 - 958
  • [28] Long-term outcomes of people living with HCV/HIV with advanced hepatic fibrosis treated with direct-acting antivirals: a retrospective study
    Matos, Joao
    Caetano, Ines
    Faria, Flavia
    Novela, Francisco
    Vasconcelos, Antonio Ludgero
    Mendez, Josefina
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2024, 27 : 324 - 325
  • [29] Real-world effectiveness of genotype-specific and pangenotypic direct-acting antivirals in HCV-infected patients with renal failure
    Tronina, Olga
    Brzdek, Michal
    Zarebska-Michaluk, Dorota
    Lorenc, Beata
    Janocha-Litwin, Justyna
    Berak, Hanna
    Sitko, Marek
    Dybowska, Dorota
    Mazur, Wlodzimierz
    Tudrujek-Zdunek, Magdalena
    Janczewska, Ewa
    Klapaczynski, Jakub
    Dobracki, Witold
    Parfieniuk-Kowerda, Anna
    Krygier, Rafal
    Socha, Lukasz
    Flisiak, Robert
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2023, 9 (04) : 320 - 334
  • [30] Circulating IL-13 Is Associated with De Novo Development of HCC in HCV-Infected Patients Responding to Direct-Acting Antivirals
    Jilkova, Zuzana Macek
    Seigneurin, Arnaud
    Coppard, Celine
    Ouaguia, Laurissa
    Aspord, Caroline
    Marche, Patrice N.
    Leroy, Vincent
    Decaens, Thomas
    CANCERS, 2020, 12 (12) : 1 - 7
12345